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ABSTRACT Thombospondin, the major glycoprotein released from a-granules of thrombin-
stimulated platelets, is a disulfide-bonded trimer of 160 kilodalton subunits and apparently
functions as a platelet lectin. Because cultured human umbilical vein endothelial cells synthe-
size and secrete a glycoprotein (GP-160) which is a disulfide-bonded multimer of 160 Walton
subunits, the possibility that GP-160 is thrombospondin was investigated . Tritiated GP-160
could be immunoisolated from [3H]leucine-labeled endothelial cell postculture medium using
a rabbit antiserum to human platelet thrombospondin. Thrombospondin and GP-160 comi-
grated in two different two-dimensional electrophoretic systems. Both proteins are disulfide-
bonded trimers of acidic 160-kdalton subunits. A competitive radioimmunoassay for binding
of ' 25 1-thrombospondin to the rabbit antibodies indicated that 49 l-rg of thrombospondin
antigen per 106 confluent endothelial cells accumulated in postculture medium over 24 h.
Thus, endothelial cells secrete large amounts of a glycoprotein that is identical or very similar
to platelet thrombospondin .
Thrombospondin, also known as thrombin-sensitive protein (2,
3) or glycoprotein G (4), is a major platelet a-granule glyco-
protein that is secreted and then partially bound to platelet
membranes when human platelets aggregate in response to
thrombin (5-9). Studies by Lawler and co-workers indicate
that thrombospondin is a 450-kdalton filamentous protein of
dimensions 7 X 65 run, has a pl of 4.7, and is composed of
three large disulfide-linked subunits (10, 11). During the proc-
ess of aggregation, thrombin-stimulated platelets develop a
membrane-bound lectin activity (12-14) that originates from
a-granules and appears to play an important role in mediating
platelet aggregation by binding to a specific receptor on other
platelets (15, 16). We recently found that purified human
platelet thrombospondin has lectin activity (i.e., agglutinates
fixed trypsinized sheep erythrocytes) and blocks the aggluti-
nation of thrombin-treated platelets. Therefore, we suggested
that thrombospondin is the endogenous lectin of human plate-
lets (17). This may explain why platelets from patients with the
gray platelet syndrome, which lack a-granules and a-granule
constituents, including thrombospondin, aggregate poorly in
response to thrombin (18).
A portion ofthis work was presented to the American Society for Cell
Biology in Cincinnati, OH, November 14-18, 1980 (1).
THE JOURNAL Of CELL BIOLOGY " VOLUME 93 MAY 1982 343-348
© The Rockefeller University Press " 0021-9525/82/05/0343/06 $1.00
Cultured endothelial cells synthesize and secrete a glycopro-
tein, GP-160, which is a disulfide-bonded multimer of 160-
kdalton subunits and resists digestion with bacterialcollagenase
(19, 20). A protein with the same properties is produced by
cultured HT-1080 human sarcoma cells (21). Because of the
similarities between thrombospondin and GP-160, we under-
took the present experiments which indicate that GP-160 is
identical or nearly identical to thrombospondin.
MATERIALS AND METHODS
Materials
Humanplasma fibronectin was purified andiodinated as described previously
(22). Humanthrombin (23) and Escherichia coli RNApolymerase were generous
gifts from Dr. John Fenton, II, NewYork State Department of Health, Albany,
NY, and Dr. Richard Burgess, University ofWisconsin-Madison, Madison, WI,
respectively. The following were purchased: Type I collagenase, Worthington
Biochemicals, Freehold, NJ; L-[3,4,53H]leucine (110 Ci/mmol), carrier-free
Na"I, and Enhance, New England Nuclear, Boston, MA; X-Omat XR-2 Film,
Eastman Kodak, Co., Rochester, NY; protein A-Sepharose CL-4B, Pharmacia
Fine Chemicals, Piscataway, NJ; hírudin, molecularsizemarkers,bovine albumin
(type V), swine skin type I gelatin, and phenylmethylsulfonyl fluoride (PMSF),
Sigma Chemical Co., St. Louis, MO; Bio-Gel P-300, Bio-Gel A-15M, insolubi-
lized goat anti-rabbit immunoglobulin (Immunobeads), and reagents for SDS
PAGE, Bio-RadLaboratories, Richmond, CA,heparin-agarose, Pierce Chemical
Co., Rockford, IL; and protein A-bearing Staphylococci (IgGsorb), The Enzyme
Center, Inc., Boston, MA.
343Culture of Endothelial Cells
Human endothelial cells were derived from umbilical cord veins and cultured
in medium 199 and 2091 human serum using methods and materials previously
described (19, 24).
Radioactivelylabeled proteins synthesized and secretedby confluent endothe-
lial cells were prepared by incubating washed 75-cm' cell monolayers for 24 h at
37°C in leucine-free minimal essential medium, 10 ml per flask containing 200
ACi ofL-[3,4,53H)leucine . In experiments in which [3Iilleucine-labeled fibronec-
tin and GP-160 were isolated by gelatin-agarose chromatography, the cells were
labeled in medium containing 20% pooled human serum. In experiments in
which [3H)leucine-labeled GP-160 was immunoisolated using rabbit antithrom-
bospondin, the cellswere labeled in medium containing either 20% rabbit serum
or 0.5% tryptose phosphate broth .
In experiments in which the accumulation of thrombospondin antigen was
quantitated byradioimmunoassay, endothelialcells were cultured in medium 199
containing 20% human serum in 2-cm' wells of multiwell plates. When the cells
were confluent, the cell layer was washed, and medium containing 20% rabbit
serum was placed over the cells . After a 24-h incubation, the cell layer was
washed, and the cells were placed in 1 ml of fresh medium 199 containing 20%
rabbit serum. At various times after the second medium change, postculture
medium was removed, clarified by centrifugation at 8,000 g for 2 min in a
microfuge, and frozen for further analysis . Cells were dispersed with 0.02% (wt/
vol) collagenase and 0.01% (wt/vol) EDTA in 10 mM HEPES, 140mM sodium
chloride, pH 7 .4, and enumerated with a Coulter electronic cell counter. To rule
out the possibility that human thrombospondin might bind to endothelial cell
layer during subculture and be released slowly into the culture medium during
the 24-h preincubation and the experimental incubation in rabbit serum, we
added" 5I-thrombospondin (see below) to serum-containingmediumofconfluent
cells. After 24 h, <I%was associated with the cell layer . Human serum contained
-V65 pg/ml thrombospondin (see below), and medium plus 20% serum would
contain -13 pg/ml. Thus, <130 ng would be in the cell layer at the beginning of
the experimental incubation .
Purification and lodination of Thrombospondin
8 U of l- to 3-d-old platelet concentrate wasobtained from Badger Red Cross,
Madison, WI . Platelets were washed and reacted with thrombin as described by
Lawler et al . (10, 11) ; thrombinwas inhibited with hirudin after 2 min ofreaction.
The supernatant, 15-30 nil, was frozen in a dry-ice ethanol bath and thawed in
a 37°C bath . A small fibrin clot formed in the thawing solution; it was gently
removed with a stir rod . The supernatant was applied to a 5 x 35-cm column of
Bio-Gel P-300, equilibrated and eluted with TBS-EDTA. The first protein peak,
which typically had a peak absorbance (A"° "m . ' `m) of 0.2, was applied to a 1 .2
x 6-cm column of heparin-agarose equilibrated in TBS-EDTA . The heparin-
agarose column was washed with 10mM Tris, 140 mM sodium chloride, and I
mM EDTA, pH 7 .4 (TBS-EDTA), and thrombospondin was eluted with 0.55 M
sodium chloride in 10 mM Tris, I mM EDTA, pH 7 .4. Peak fractions from the
heparin-agarose column were pooled, portions were frozen in a dry-ice ethanol
bath, and the frozen solutions were stored at -70°C . The amount of thrombo-
spondin in the initial platelet releasate, determined by radioimmunoassay (see
below), was typically 7 .5 mg, and the yield ofpurifiedthrombospondin, assuming
that a 1 mg/ml solution has an A' 8° ""` ' - of 1.09 (11), was typically 1 .5 mg
(20% yield) . Thepurity ofthrombospondin, estimated by densitometry after SDS
PAGE, was 97% (Fig . 1) .
Thrombospondin was iodinated by the chloramine-T technique (25) . Free
iodine was removed by chromatography on Bio-Gel P-300 or extensive dialysis.
The labeled protein was mixed with PMSF-treated albumin, 1 mg/ml, snap
frozenin a dry-ice ethanol bath, and stored inportions at -70°C. Specific activity
was -0 .5 mCi/mg . Radiochemical purity was assessed by autoradiography after
SDS PAGE and found to be >95% .
Production and Characterization of
Rabbit Antithrombospondin
Thrombospondin was further purified by preparative electrophoresis after
reduction on SDS PAGE slab gels (26) . The final product, 10-20Ag in 0.3 ml of
0.1% SDS, was emulsified with an equal volume ofcomplete Freund's adjuvant
and injected into a rabbit at multiple subcutaneous sites . The injections in
complete adjuvant were repeated twice at monthly intervals . 2 wk later, I mg of
protein from the heparin-affinity column was given without adjuvant . Antiserum
was collected over the next 2 mo. Immunoglobulin from the antiserum, when
loaded onto protein A-bearing Staphylococci (27), bound ' z51-thrombospondin
and not . ..I-fibronectin. In experiments in which immune complexes were
collected with beads coated with goat anti-rabbit immunoglobulinor with protein
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FIGURE 1
￿
Purification of human platelet thrombospondin as mon-
itored by SIDS PAGE on 8% gels . Samples were reduced before
analysis . The position of thrombospondin (TSP) is indicated . Lanes :
(a) Molecular size standards : plasma fibronectin (210 kdaltons),
phosphorylase (93 kdaltons), albumin (68 kdaltons), ovalbumin (43
kdaltons), and chymotrypsinogen (24.5 kdaitons) . (b) Releasate from
platelets (9 x 109/ml) stimulated with thrombin (3 U/ml) . The
release reaction was performed in 0 .1 M HEPES, 0.15 M sodium
chloride, pH 7 .6, containing 5 mM glucose and 2 .5 mM EDTA for 2
min at 37°C . (c) Releasate from thrombin-stimulated platelets after
freezing and thawing . (d) Clot that was recovered after freezing and
thawing of platelet releasate . (e) Purified human plasma fibrinogen .
(f) First protein peak from Bio-Gel P-300 column . (g) Unbound
fraction from heparin-agarose affinity column . (h) Protein eluted
from heparin-agarose affinity column by 0.55 M sodium chloride.
Protein loads: lane a, 5 fug per band ; lane b, 7 Ag; lane c, 9.51íg ; lane
e, 5 Ag; lane f, 3 Ag ; lane g, 0 .4 Ag ; and lane h, 6 .5 líg . In other
experiments, the f3' subunit of E. coliRNA polymerase,150 kdaltons,
was used to assign a molecular size of 160 kdaltons to thrombo-
spondin . The a and # chains of platelet fibrin are slightly smaller
than the Aa and Bf3 chains of fibrinogen because of loss of the A
and B fibrinopeptides .
A-bearingStaphylococci, maximum binding of75 ng of `Z'1-thrombospondin was
obtained with 1 ml ofa 1:1,000 dilution of antiserum .
Radioimmunoassay of Thrombospondin
Protein A-bearing Staphylococci were armed with antithrombospondin as
described by O'Keefe and Bennett (27) . Approximately 90% of . ..I-thrombo-
spondin bound when mixed with an equal volume of a 10% (wt/vol) suspension
of armed Staphylococci (Fig. 2A). Standard or unknown in physiologic saline
solution, 100 Al, was mixed with ...I-thrombospondin, -2 x 10 ° cpm in 100 Al,
and then with 100 Al of a suspension that consisted of one part 10% armed
Staphylococci and nine parts 10% "unarmed" carrier Staphylococci . After 3 h at
4°C, the mixture was centrifuged for I min at 10,000 g in a microfuge, the
supernatant was discarded, and the pelletwas analyzed in a gamma counter . The
assay was sensitive to 0 .7 pg/ml thrombospondin (Fig. 2 B). Fibronectin, 200 ttg/
ml, didnotinhibitin the assay . By the assay,the concentration ofthrombospondin
in serum (formed by allowing human blood in glass tubes to clot at 37°C for I
h) was 65 ± 23 pg/ml (R ± SD, n = 6) .
lmmunoisolation and Analysis of[3H]Leucine-
labeled Endothelial Cell Proteins
Tritiated leucine-labeled endothelial cell medium was made 3% in SDS and
6 M in urea, heated in a boiling water bath for 5 min, dialyzed against two
changes of3% SDS in phosphate-buffered saline (PBS), diluted 10-fold with 0.12tn
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FIGURE 2
￿
Radioimmunoassay of thrombospondin. Panel A shows
the binding of . ..1-thrombospondin to various ratios of armed and
carrier protein A-bearing Staphylococci. Nonspecific binding to
Staphylococci armed with normal rabbit serum was 15% (dashed
line) . The arrow points to the ratio of armed and "unarmed"
Staphylococci that was used in the radioimmunoassay. Panel B
shows typical inhibition curves in the radioimmunoassay: ", purified
human platelet thrombospondin standard; ", supernatant from
confluent human umbilical vein endothelial cells after 24 h in
culture medium containing 20% rabbit serum; and A, medium after
24 h in culture plates that contained no cells. The lower dashed line
represents nonspecific binding to Staphylococci armed with normal
rabbit serum and the upper dashed line represents binding to
antibody-armed and carrier Staphylococci in the absence of unla-
beled thrombospondin. Total 1251-thrombospondin was 1.9 x 10°
cpm per assay.
M sodium chloride, 33 mM Tris acetate, pH 8.5, and made 1.7% in Triton X-100
(28). The mixed micellar solution, 30 ml, was incubated with 5 lal of rabbit
antithrombospondin, preimmunization serum from the antithrombospondin rab-
bit, rabbit antifrbronectin (19), or rabbit antiovalbumin (19) previously coupled
to 10 lrl of protein A-Sepharose. After overnight incubation with end-over-end
rotation at 20°C, the beads were centrifuged, washed eight times with 2 M urea,
0.1 Mglycine, 1% Triton X-100 (28), and eluted by boiling in 2% SDS, 6 M urea.
Immunoisolated labeled proteins were analyzed by electrophoresis in SDS in
continuous 3% acrylamide-0.5% agarose gels with and without reduction (19).
Unlabeled purified fibronectin and thrombospondin were analyzed in simulta-
neously run gels. Unlabeled proteins were visualized by staining with Coomassie
Brilliant Blue. Thegels containing radioactive proteins were sectioned into 2-mm
slices, and each slice was processed for liquid scintillation counting as previously
described (l9).
Partial Purification of [3H]leucine-labeled GP-
160 and Fibronectin on Gelatin-Agarose
Purified plasma frbronectin, 12 mg, was added to 25 ml of[3H]leucine-labeled
endothelial cell postculture medium, and the mixture was applied to a 1.5 x 12-
cm column ofgelatin-agarose. The column support consisted ofgelatin coupled
to cyanogen bromide-activated Bio-Gel A-15M by the method of March et al.
(29). Unlabeled fibronectin, tritiated fibronectin, and tritiated GP-160 bound to
the column. Thecolumn was washed with PBS-EDTA, and bound proteins were
eluted with IM sodium bromide, 20 mM sodium acetate, pH 5.0. The eluted
proteins were dialyzed against TBS, snap frozen, and kept at -70°C until further
studies were performed.
Polyacrylamide Slab Gel Electrophoresis
One-dimensional SDS PAGE was performed using the discontinuous slab gel
system of Ames (30). Size markers included reduced fibronectin, 210 kdaltons;
ß' aubunit of RNA polymerase, 150 kdaltons; f3-galactosidase, 116 kdaltons;
phosphorylase, 93 kdaltons; albumin, 68 kdaltons; ovalbumin, 43 kdaltons; and
chymotrypsinogen, 24.5 kdaltons. Two-dimensional gel electrophoresis, in which
reduced proteins were separated by isoelectric focusing in 8 M urea in the first
dimension and SDS PAGE in the second dimension, was performed as described
by Anderson and Anderson (31). Nonreduced-reduced two-dimensional SDS
PAGE was performed by the method of Phillips and Poh Agin (32) with slight
modifications. The first-dimension discontinuous gel was cast in 0.3 (i.d.) x 12-
cm tubes. After electrophoresis without reduction, the first-dimension gel was
incubated in sample buffer containing l% ß-mercaptoethanol. The gelwas bound
to the top of the second-dimension discontinuous slab gel by 1% agarose made
up in sample buffer. After polymerization of the agarose, a small slot was made
to the right (bottom) ofthe cylindrical gel, and size markers were analyzed along
side the proteins in the cylindrical gel. Nonreduced plasma fibronectin was
assumed to have a size of 420 kdaltons. Slab gels were stained with Coomassie
Brilliant Blue, prepared for fluorography by incubation in Enhance, and dried
onto filter paper. The comers ofthe paper were marked with ink that contained
['°C]glucose before the gel was placed against film. After the fluorogram was
developed, alignment of the radioactive ink lines allowed exact comparisons of
radioactive spots and protein-staining spots.
RESULTS
Cultured human endothelial cells were incubated with [3H]-
leucine, and the metabolically labeled proteins that were se-
creted into the medium were analyzed by SDS PAGE with and
without reduction (Fig. 3A). Without reduction, 31% of the
[3H]leucine migrated in a peak that had an apparent size of
450 kdaltons. With reduction, the peak at 450 kdaltons disap-
peared and was replaced by peaks with apparent sizes of 220
and 160 kdaltons. The 220-kdalton peak, which accounted for
17% of the labeled proteins, has been shown previously to be
fibronectin (19, 33, 34). The 160-kdalton peak accounted for
14% of the labeled proteins.
When rabbit antithrombospondin serum was reacted with
[3H]leucine-labeled postculture medium, antithrombospondin
specifically immunoisolated 3H-labeled protein with apparent
sizes of 450 kdaltons when analyzed without reduction (Fig.
3 B) and 160 kdaltons when analyzed with reduction (Fig. 3 C).
Purified human platelet thrombospondin, electrophoresed as a
marker, migrated in SDS PAGE with the immunoisolated 160-
Walton [3H]leucine-labeled peak when analyzed after reduc-
tion and with the immunoisolated 450-kdalton [3H]leucine-
labeled peak when analyzed without prior reduction (Fig. 3,
arrows). No labeled proteins were specifically isolated in con-
trol experiments with antiovalbumin (Figs. 3 B and C) or with
preimmune serum from the antithrombospondin rabbit. Im-
munoisolation of the 160-kdalton protein was not blocked by
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FIGURE 3 Analysis
of [3H]leucine-la-
beled postculture
medium and immu-
noisolated [3H]leu-
cine-labeled GP-
160 . The following
samples were ana-
lyzed by SDS PAGE :
i
￿
A, unfractionated
postculture medium
EE
￿
without (solid line)
6
or with (dashed
line) prior reduc
TSP
￿
tion ; 8, labeied pro-
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￿
munoisolated with
° loo
￿
antithrombospon-
din (dashed line)
or antiovalbumin
(solid line) and an-
alyzed without reduction ; and C labeled protein isolated with
antithrombospondin (dashed line) or antiovalbumin (solid line) and
analyzed with reduction . Arrows point to the positions of migration
of nonreduced (450 kdaltons) and reduced (160 kdaltons) marker
thrombospondin . In parallel gels, we found that [ 3 H]fibronectin
bound to antifibronectin and migrated at slice 10 without reduction
and slices 14 and 15 with reduction and that there was only back-
ground binding to preimmune serum . Size standards are described
in Fig . 1 .
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preadsorption of the antithrombospondin antiserum (5 ILI) with
purified fibronectin (100 ug) .
In the presence of purified fibronectin (0.5 mg/ml in PBS),
[3H]leucine-labeled endothelial cell fibronectin and GP-160
bound to gelatin-agarose and could be eluted with acetate-
buffered 1 M NaBr, pH 5 (Fig . 4) . SDS PAGE of unbound
and bound fractions (Fig . 4) and calculations of yields of
labeled proteins indicated that affmity chromatography on
gelatin-agarose in the presence of unlabeled fibronectin re-
sulted in nearly quantitative recovery of [3H]leucine-labeled
fibronectin and [3H]leucine-labeled GP-160 . To make further
comparisons between thrombospondin and [3H]Ieucine-labeled
GP-160, thrombospondin was added to the mixture of unla-
beled fibronectin, [3H]leucine-labeled endothelial cell fibronec-
tin, and [ 3H]leucine-labeled endothelial cell GP-160 . The four
proteins were then analyzed by two different two-dimensional
electrophoretic systems : isoelectric focusing of reduced proteins
in 8M urea followed bySDSPAGE (Fig. 5A) and SDS PAGE
without reduction followed by SDS PAGE after reduction
(Fig . 5B) . GP-160 was acidic (Fig . 5A, left), had an apparent
size of 450 kdaltons in its unreduced form (Fig. 5 B, left), and
was apparently a disulfide-bonded trimer of 160-kdalton sub-
units (Fig . 5 B, left) . GP-160 migrated at exactly the same
positions as thrombospondin in both two-dimensional systems.
GP-160 and thrombospondin exhibited the same limited isoe-
lectric heterogeneity (Fig. 5 A) . In contrast, labeled endothelial
cell fibronectin was slightly larger than plasma fibronectin in
its reduced (220 vs . 210 kdaltons) and unreduced forms and
thus migrated slightly higher and more to the left in the
nonreduced-reduced system (Fig. 5 B) . There were also slight
differences in isoelectric heterogeneity between endothelial cell
and plasma fibronectins (Fig. 5A) .
Thrombospondin antigen was first detectable by radioim-
munoassay in the postculture medium of confluent endothelial
cells after 8 h of culture ; after 24 h the postculture medium
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FIGURE 4 Chroma-
tography of a mix-
ture of purified
plasma fibronectin
and [ 3H]leucine-la-
beled postculture
medium on gelatin-
agarose as moni-
tored by SDS PAGE
on 6% gels . Samples
were reduced be-
fore analysis, and
radioactive bands
were detected by
fluorography . Lanes
are (a) unfraction-
ated proteins, (b)
proteins not bound
to gelatin-agarose,
and (c) proteins
bound to gelatin
agarose and eluted
with 1 M sodium
bromide, pH 5 .0 . Of
the many proteins in
the serum-contain-
ing growth medium
that could be de-
tected with Coo-
massie Brilliant
Blue, only fibronec-
tin bound to gela-
tin-agarose . Unla-
beled fibronectin
disturbed the band
ing pattern of [3H]leucine-labeled fibronectin and caused the rare-
faction on the fluorogram in the fibronectin (FN) region, The
positions of thrombospondin ( TSP, electrophoresed as a marker)
and of human albumin (68 kdaltons, detected by protein staining in
lanes a and b) are indicated . Labeled proteins< 60 kdaltons in size
migrated at the dye front .
contained 49 Itg/106 cells (Table I).' The curves for inhibition
of
' z .I-thrombospondin binding to rabbit antibodies were sim-
ilar for purified platelet thrombospondin and endothelial cell-
conditioned medium, although we could not construct a full
inhibition curve for conditioned medium because ofits limited
antigen concentration (Fig. 2B) . The value of 4.4 wg throm-
bospondin/ml of 24-h conditioned medium is comparable to
the value of 5.2 jLg fibronectin/ml of72-h conditioned medium
that we determined earlier (19) .
DISCUSSION
Several different comparisons of GP-160 synthesized and se-
creted by cultured endothelial cells and thrombospondin se-
creted by thrombin-stimulated platelets indicate that these two
proteins are the same . GP-160 and thrombospondin migrated
identically in two different two-dimensional gel systems. There-
fore, it seems likely that the differences between GP-160 and
thrombospondin, if present, are minor.
Since submission of this manuscript, McPherson et al . (35)
have described the isolation and characterization of a glyco-
' Recently, we developed an enzyme-linked immunoabsorbent assay
(ELISA) for human thrombospondin based on a mouse monoclonal
IgG antibody to thrombospondin isolated from platelets. Analyses of
human thrombospondin in the 24-h tissue culture medium by ELISA
agree within 40% of the values obtained by radioimmunoassay .FIGURE 5
￿
Two-dimensional analyses of fibronectin (FN), GP-160, and thrombospondin ( TSP) . The following mixture of proteins
was analyzed : plasma fibronectin, platelet thrombospondin, and [3HJIeucine-labeled endothelial cell fibronectin and GP-160. Two
systems were used : A, isoelectric focusing (pH, acid side to the left) in 8 M urea followed by electrophoresis through 6%
polyacrylamide in SDS after reduction (R) ; and 8, electrophoresis through 4% polyacrylamide in SIDS without reduction (NR)
followed by electrophoresis through 6% polyacrylamide in SDS after reduction (R) . The slabs were stained for protein and dried
onto filter paper (right) and analyzed by fluorography (left) . Apparent size in kilodaltons is indicated on the right . Standards are
described in Fig . 1 . The figure has been made to allow one-for-one comparisons of fluorographic and protein-staining patterns .
We could make a more critical evaluation by overlaying the dried stained gel with the developed fluorography film .
TABLE I
Accumulation of Thrombospondin Antigen in Culture
Medium ofHuman Umbilical Vein Endothelial Cells as
Ascertained by Radioimmunoassay
*z±SD, n=3.
protein from serum-free conditioned media of bovine aortic
endothelial cells which is apparently homologous to human
endothelial cell GP-160 . Following our lead (1), McPherson et
al . (35) compared the glycoprotein to thrombospondin . The
amino acid composition of the glycoprotein was similar to that
published for human platelet thrombospondin, antibodies to
the glycoprotein reacted with bovine thrombospondin after
electrophoretic transfer from SDS polyacrylamide gels onto
nitrocellulose paper, and two-dimensional peptide maps ofthe
iodinated glycoprotein and iodinated thrombospondin were
similar. Thus, thrombospondin synthesis by endothelial cells
in culture must be a general phenomenon .
Although thrombospondin and GP-160 are disulfide-bonded
trimers of 160-kdalton subunits, there is no evidence that
thrombospondin and GP-160 are collagenous . We have been
able to degrade human endothelial cell GP-160 using purified
bacterial collagenase (unpublished experiments carried out in
both of our laboratories) . Similarly, Sage et al. (20) were unable
to degrade bovine endothelial GP-160 by purified bacterial
collagenase under conditions in which type III procollagen was
readily degraded . By amino acid analysis, thrombospondin is
not rich in proline or glycine (3, 10) .
We are unsure of the determinants ofbinding of [3H]leucine-
labeled GP-160 to gelatin-agarose in the presence of unlabeled
fibronectin. In preliminary studies, we found that >60% of "sI-
thrombospondin bound to gelatin-agarose, underived agarose,
or Bio-Gel P-300 . The presence of fibronectin had little influ-
ence on this apparently nonspecific binding . Thus, while chro-
matography on gelatin-agarose in the presence of fibronectin
allowed us to partially purify GP-160, a better experimental
system is needed to allow investigation of specific binding.
We can only speculate on the function(s) of endothelial cell
thrombospondin . As described above, thrombospondin is se-
creted and bound by thrombin-activated platelets (2-9) and
MOSHER ET AE.
￿
Thrombospondin Production by Endothelial Cells
￿
347
Culture
h
Thrombospondin
Aglml
antigen*
jug/708
cells
0 <0 .7 <7
4 <0 .7 <7
8 0.8 ± 0.1 10 ± 1
14 3.4±0 .8 36±6
24 4.4±0.2 49±4apparently mediates thrombin-induced aggregation (12-17).
Two proteins, von Willebrand factor and fibronectin, are also
found in platelet a-granules (36-39), bind to the surface of
thrombin-stimulated platelets (40-42), and are synthesized by
endothelial cells (19, 33,34,43,44). VonWillebrand factor and
fibronectin are found in plasma and in the subendothelium
(45, 46). Von Willebrand factor mediates platelet adhesion to
subendothelium (47, 48) whereas the role of fibronectin in
platelet function is unknown. Although plasma thrombospon-
dinlevels as measured by radioimmunoassay are quitelow(- 1
lug/ml, our unpublished data), endothelial cells may, when
appropriately stimulated, release thrombospondin into local
microenvironments andthus support platelet interactions with
endothelial cells and the subendothelium. Thrombospondin,
because of its lectin activity, may also play important roles in
the interaction of endothelial cells with each other and with
the underlying extracellular matrix. Experiments to test these
hypotheses are currently underway.
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